1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Alisa Pedrana

Associate Professor Alisa Pedrana

Senior Research Fellow; Deputy Discipline Head, Public Health; Eliminate Hepatitis C Australia Coordinator

Taking students
Associate Professor Alisa Pedrana

Background

Associate Professor Alisa Pedrana BBmedSc (hons), PhD (Public Health) is a senior research fellow and public health practitioner, who co-leads the Public Health discipline at Burnet Institute. She holds an adjunct research fellow position at Monash University and Co-lead’s the Health Services Research and Implementation Platform at Monash Partners.

Her research focusses on Blood-borne virus/Sexually Transmitted Infections epidemiology and the integration of health interventions and evaluation to inform health services and quality of care improvements. Her current work on Hepatitis C elimination uses implementation science and co-design approaches to strengthen health systems and works closely with community organisations to produce evidence to support decision and policy making.

In her current role as coordinator of the Eliminate Hepatitis C Australia Partnership, a $11.3M national project, she leads a multi-disciplinary team of over 80+ researchers, implementation scientists, government workers, and health services and community organisation members to develop a cohesive national response to increase hepatitis C testing and treatment.

She has published over 100 peer-reviewed articles in leading local and international journals, and delivered over 50 presentations at local, national, and international conferences. Over the past five years she has secured $25 million in competitive research grants and tender funds as a lead investigator.

Qualifications

  • 2012: PhD Monash University, Melbourne, Australia
  • 2005: BA Biomedical Science (Hons), Monash University, Melbourne, Australia
  • 2004: BA Biomedical Science, Monash University, Melbourne, Australia

Appointments

  • 2020 – present: Senior Advisor, Know COVID19 Executive, Burnet Institute
  • 2019 – present: Senior Research Fellow, Disease Elimination Program, Burnet Institute
  • 2019 – present: Co-Lead Health Services Research and Implementation Platform, Monash Partners
  • 2014 – present: Adjunct Research Fellow, Department of Epidemiology and Preventive Medicine, Monash University

Awards

  • 2022: Victorian Near-miss Award recipient
  • 2021: Burnet - NHMRC ‘near-miss' fellowship
  • 2020: Hepatitis Victoria LiverWELL Individual Contribution Award
  • 2014-2017: National Health and Medical Research Council, Early Career Fellowship
  • 2013: Monash University Outstanding Support of Peers Award – PhD
  • 2013: Monash University Bridging Postdoctoral Fellowship
  • 2012: Endeavour Executive Award Holder
  • 2012: Scholarship Recipient for the International Union against Sexually Transmitted Infections Conference
  • 2012: Monash Postgraduate Publications Award
  • 2011: Monash University Postgraduate Travel Grant Award
  • 2009: National Health and Medical Research Council Postgraduate Scholarship Award
  • 2009: Sidney Myer Health Scholarship Award
  • 2009: Burnet Institute Public Health Travel Award
  • 2009: Best Oral Presentation: HIV Prevention, Australasian Society for HIV Medicine Australasian HIV/AIDS Conference
  • 2005: Runner Up; VicHealth Health Promotion Project Award

Positions

  • 2020 – present: Knowledge Translation Lead, Optimise COVID-19 Study
  • 2019 - present: EC Partnership Australia Coordinator, Burnet Institute
  • 2016 - 2021: EC Partnership Victoria Coordinator, Burnet Institute
  • 2014 - 2017: Postdoctoral Research Fellow, Department Nutrition, Harvard T.H Chan School of Public Health
  • 2013 - 2018: ICT and Evaluation Advisor, Jhpiego
  • 2014 - 2016: mHealth Specialist, SUMMIT Institute of Development
  • 2012 - 2015: Visiting Research Fellow and mHealth Advisor, RTI Indonesia
  • 2012: Advanced Public Health Officer, Queensland Health, Cairns Public Health Unit, Cairns

Reports + Policy Briefs

2022 (2)

2021 (6) 

Reports and other work

  • The Optimise Study: COVID-19 vaccine intention, and adherence to isolation and quarantine recommendations. (PUBLIC HEALTH REPORT)

    The Optimise Study: COVID-19 vaccine intention, and adherence to isolation and quarantine recommendations. (PUBLIC HEALTH REPORT)
  • The Optimise Study: Social networks and mixing patterns

    This report focuses on: Average overall contacts between October 2020 and March 2021, Average contacts per setting, over time, The impact of contacts on mood and the influence of people's social network on attitudes toward vaccination.

    The Optimise Study: Social networks and mixing patterns
  • 2019: Australia’s progress towards hepatitis C elimination annual report

    Hepatitis C poses a significant public health concern in Australia, with over 170,000 individuals estimated to be living with chronic hepatitis C infection as of the beginning of 2017. Until the availability of direct-acting antivirals (DAAs) for all Medicare-eligible Australians with hepatitis C infection on March 1st, 2016, there was a growing population of individuals living with hepatitis C. This trend was accompanied by an increasing burden of liver disease, rising rates of liver cancer, and premature deaths attributed to long-term hepatitis C infection.

    2019: Australia’s progress towards hepatitis C elimination annual report
On this page